PRAC adopted safety updates to the product information to introduce a new warning on hemophagocytic lymphohistiocytosis and add it to the list of adverse drug reactions with a frequency of not known, based on a drug safety report. (European Medicines Agency) - Oct 25, 2026 - Pharmacovigilance Risk Assessment Committee (PRAC) Minutes
of meeting on 31 Aug – 3 Sep 2026:
Consequently, sections 4.2, 4.4, and 4.8 of the SmPC were updated, with
corresponding revisions to the Package Leaflet. RMP version 6.0 was also
submitted.
PRAC • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology
|